Surgery Shows No Survival, Morbidity Benefit for Mild Hyperparathyroidism - Medscape

4/18/2022 12:00:00 AM3 yearsago
by Nancy A. Melville
by Nancy A. Melville
With more than 10 years of follow-up, a randomized trial shows nearly identical outcomes in most measures among patients with mild parathyroid tumors who did and did not receive parathyroidectomy.
Patients who receive parathyroidectomy for mild primary hyperparathyroidism show no benefits in survival or morbidity, including fractures, cancer, or cardiovascular outcomes over more than 10 years,… [+5889 chars]
full article...